Impact of COVID-19 Outbreak on Antihypertensive, Global and Japan Market Insights, Forecast to 2026

Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due to hypertension.

Market Analysis and Insights: Global and China Antihypertensive Market

This report focuses on global and China Antihypertensive market.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antihypertensive QYR Global and China market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Antihypertensive QYR Global and China industry.

Based on our recent survey, we have several different scenarios about the Antihypertensive QYR Global and China YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 19250 million in 2019. The market size of Antihypertensive QYR Global and China will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Antihypertensive Scope and Market Size

Antihypertensive market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antihypertensive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

For China market, this report focuses on the Antihypertensive market size by players, by Type, and by Application, for the period 2015-2026. The key players include the global and local players which play important roles in China.

Segment by Type, the Antihypertensive market is segmented into

Diuretics

Angiotensin receptorblockers (ARBs)

Angiotensin converting enzyme (ACE) inhibitors

Beta blockers

Alpha blockers

Calcium channel blockers

Renin inhibitors

Vasodilators

Segment by Application, the Antihypertensive market is segmented into

Hosptial

Clinic

Home

Regional and Country-level Analysis

The Antihypertensive market is analysed and market size information is provided by regions (countries).

The key regions covered in the Antihypertensive market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Antihypertensive Market Share Analysis

Antihypertensive market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antihypertensive business, the date to enter into the Antihypertensive market, Antihypertensive product introduction, recent developments, etc.

The major vendors covered:

Pfizer

Novartis

Sanofi

Merck

Boehringer Ingelheim

Lupin

Johnson & Johnson

Astra Zeneca

Daiichi Sankyo

Ranbaxy

 

 

Radiofrequency (RF) ablation devices market is projected to yield $1260 Million by 2025

With managing chronic pain is much more when compared to cardiovascular diseases or cancer. There are various measures being taken to eliminate chronic pain and radiofrequency (RF) ablation devices are gaining acceptance as the non-invasive method of ablation for pain management. Diabetic neuropathy, complex regional syndrome, sacroiliac pain, and other specific conditions such as discherniation can be efficiently treated with radiofrequency ablation.  In recent years, awareness about the non-invasive method for pain management has increased. In addition, high availability of variety of products, easy access, cost-effectiveness, and quick relief have subsequently added to the growth of the global radiofrequency ablation devices for pain management market. The augmented adoption rate of radiofrequency ablation procedures is projected to yield $1260 Million in 2025 from a humble valuation of $372.7 Million in 2015, with a remarkable 13.0% CAGR, according to findings by Crystal Market Reports. 

Artificial Limbs Market Is expected to grow $3.02 billion by the end of 2026

With the increasing incidence of road accidents, sports injuries, and genetic diseases, the market for artificial limbs is witnessing a tremendous rise across the world. Technological advancements in mechanical devices that offer assistance to individuals with amputation in performing everyday-duties are also supporting the growth of this market substantially and are likely to continue doing this in the years to come. The opportunity in the global market is increasing at a healthy CAGR of 5.7% between 2018 and 2026, expanding from $1.79 billion in 2017 to $3.02 billion by the end of 2026. The key products available in the global artificial limbs market are lower extremity prosthetics, upper extremity prosthetics, liners, and sockets. Among these, the demand for lower extremity prosthetics is comparatively higher and is expected to remain so over the forthcoming years, thanks to the increasing prevalence of vascular diseases and the augmenting number of road accidents across the world.

Global embedded systems market is projected to be worth $300 Billion by the end of 2025

The use of embedded systems has grown extensively over the last few years, particularly in the automotive industry. Multi-core technology equipment is in high demand across several industry verticals and are highly being appreciated. This type of embedded graphic systems has now turned out to be a backbone of the consumer electronics sector. Manufacturers of embedded technology are also looking forwards to gain from the opportunities arising from the telecommunications, aerospace, defence, and healthcare industries. The competition among the players operating in the market is expected to be relatively high over the coming years owing to the sizeable shares accounted by a few key companies. As a result, most of these manufacturers are catering directly to the consumer electronics sector and are thus completely reliant on the sector’s demand for production rates and profit.  The global embedded systems market is likely to exhibit a 6.4% CAGR between 2015 and 2025. The market is projected to be worth USD 300 Billion by the end of 2025.